COMETS Membership
The COnsortium of METabolomics Studies (COMETS) advances metabolomic epidemiology by facilitating collaborations among prospective cohort studies that perform metabolomic profiling of individuals. Participating cohorts must collect blood metabolomics data on at least 100 participants and follow-up for clinically relevant outcomes. Every participating cohort is allowed one representative on the COMETS Steering Committee.
Current COMETS Executive Committee Members
Chair:
Marinella Temprosa, Ph.D.
George Washington University
Representing the Diabetes Prevention Program Outcomes Study (DPPOS)
ella@bsc.gwu.edu
Vice-Chair:
Rachel Kelly, Ph.D., M.P.H.
Harvard Medical School and Brigham and Women’s Hospital
Representing the Vitamin D Antenatal Asthma Reduction Trial (VDAART)
hprke@channing.harvard.edu
Secretary:
Rachael Stolzenberg-Solomon, M.D., Ph.D., R.D.
National Cancer Institute
Representing the Shanghai Physical Activity Study (SPA)
rachael.solomon@nih.gov
Members:
Su Chu, Ph.D.
Harvard Medical School and Brigham and Women’s Hospital
Representing the Normative Aging Study (NAS)
su.chu@channing.harvard.edu
Luciana Crotti Espinoza, Ph.D.
National Cancer Institute
Program Director
luciana.crottiespinoza@nih.gov
Kelly Crotty, Ph.D.
National Cancer Institute
Program Director
Kelly.crotty@nih.gov
Priyadarshini Kachroo, Ph.D., M.S.
Harvard Medical School
Representing the MGB Biobank Asthma study
reprk@channing.harvard.edu
Donghai Liang, Ph.D.
Emory University
Representing the Emory African American Maternal-Child Cohort (Emory AA Maternal-Child Cohort)
donghai.liang@emory.edu
Steven Moore, Ph.D., M.P.H.
National Cancer Institute
Representing Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
moorest@mail.nih.gov
Mukesh Verma, Ph.D.
National Cancer Institute
Program Director
vermam@mail.nih.gov
Maura Walker, M.S., Ph.D.
Boston University
Representing the Framingham Heart Study
mewalker@bu.edu
Danxia Yu, Ph.D.
Vanderbilt University Medical Center
Representing the Shanghai Women’s Health Study (SWHS)
danxia.yu@vumc.org
Past Members: Kathryn Rexrode, Bo Chawes, Svati Shah, Jessica Lasky-Su, Vicky Stevens, Demetrius Albanes, Ewy Mathé, Bing Yu, Craig Wheelock.
Current COMETS Steering Committee Members
Demetrius Albanes, M.D.
National Cancer Institute
Representing the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (ATBC)
daa@nih.gov
Clara Barrios Barrera, M.D.
Hospital del Mar, Barcelona
Representing the Genodiab-Mar Cohort (GDM)
clarabarrios@hotmail.es
Yoav Ben-Shlomo, Ph.D.
University of Bristol
Representing the Caerphilly Prospective Study (CaPS)
y.ben-shlomo@bristol.ac.uk
Russell Bowler, M.D., Ph.D.
National Jewish Heritage
Representing the COPD Gene Epidemiology (COPD Gene)
bowlerr@njhealth.org
Hermann Brenner, M.D.
German Cancer Research Center
Representing the Epidemiological Study on the Chances of Cure, Early Detection, and Optimized Therapy of Chronic Diseases in the Elderly Population (ESTHER)
h.brenner@dkfz.de
Stefanie Brezina, M.Sc.
Medical Univeristy of Vienna
Representing the COloRectal Cancer Study of Austria (CORSA)
stephanie.brezina@meduniwien.ac.at
Qiuyin Cai, M.D., Ph.D.
Vanderbilt University Medical Center
Representing the Southern Community Cohort Study (SCCS)
qiuyin.cai@vumc.org
Bo Chawes, M.D., Ph.D., D.M.Sci.
University of Copenhagen
Representing the COpenhagen Prospective Studies on Asthma in Childhood (COPSAC)
chawes@copsac.com
Ching-Lung Cheung, Ph.D.
University of Hong Kong
Representing the Hong Kong Osteoporosis Study (HKOS)
lung1212@hku.hk
Emily Chew, Ph.D.
National Eye Institute
Representing the Age-Related Eye Disease Study (AREDS)
echew@nei.nih.gov
Carlos Cruchaga, Ph.D.
Washington University in St. Louis
Representing the Knight ADRC and Nuerogenomics and Informatics Cohort (NGI)
cruchagac@wustl.edu
Heather Eliassen, Ph.D.
Harvard Medical School and Brigham and Women's Hospital
Representing the Nurses' Health Study (NHS) and Nurses' Health Study II (NHS II)
nhahe@channing.harvard.edu
Mohsen Ghanbari, Ph.D.
Erasmus University Medical Center
Representing the Rotterdam Study (RS)
m.ghanbari@erasmusmc.nl
Rebecca Graff, Sc.D.
University of California, San Francisco
Representing the Health Professional Follow-up Study (HPFS)
rebecca.graff@ucsf.edu
Sei Harada, M.D., Ph.D.
Keio University
Representing the Tsuruoka Metabolomic Cohort Study (TMCS)
seiharada@keio.jp
Aki Havulinna, D.Sc.
Finnish Institute for Health and Welfare
Representing Health 2000, Finrisk 1997, Finrisk 2002, Finrisk 2007, and Finrisk 2012
aki.havulinna@thl.fi
David Herrington, M.D.
Wake Forest School of Medicine
Representing the Multi-Ethnic Study of Atherosclerosis (MESA)
rdwhite@wakehealth.edu
Joel Hirschhorn, M.D., Ph.D.
Broad Institute
Representing The Estonian Biobank (EBB)
joel.hirschhorn@childrens.harvard.edu
Ann Hsing, Ph.D.
Stanford Prevention Research Center
Representing the Breast Cancer Family Registry (BCFR) and Well for Life-China (WELL-CHINA)
annhsing@stanford.edu
Deeba Husain, M.D.
Harvard Medical School
Representing the Age Related Macular Degenerated Cohort (AMD)
deeba_husain@meei.harvard.edu
Mazda Jenab, Ph.D.
International Agency for Research on Cancer
Representing the European Prospective Investigation into Cancer and Nutrition (EPIC)
jenabm@iarc.fr
Mattias Johansson, M.D.
International Agency for Research on Cancer
Representing the Northern Sweden Health and Disease Study (NSHDS)
johanssonm@iarc.fr
Hector Keun, D.Phil
Imperial College London
Representing the Human Early Life Exposome Study Sub-cohort (HELIX)
h.keun@imperial.ac.uk
Mika Kivimaki, Ph.D.
University College London
Representing the Whitehall-II study (WH-II)
m.kivimaki@ucl.ac.uk
Bruce Kristal, Ph.D.
Harvard Medical School and Brigham and Women’s Hospital
Representing the Multi-ethnic Cohort (MEC)
bruce.kristal@gmail.com
Wassim Labaki, M.D., M.S.
University of Michigan
Representing the SubPopulations and InteRmediate Outcome Measures in COPD Study (SPIROMICS)
wlabaki@med.umich.edu
Rikard Landberg, M.Sc., Ph.D.
Chalmers University of Technology
Representing the Swedish Infrastructure for Medical Population-based Life-course and Environmental Research (SIMPLER)
rikard.landberg@chalmers.se
Claudia Langenberg, M.D., Ph.D.
University of Cambridge School of Clinical Medicine
Representing the Fenland Study
claudia.langenberg@mrc-epid.cam.ac.uk
Jessica Lasky-Su, Sc.D.
Brigham and Women’s Hospital
Representing the Childhood Asthma Management Program (CAMP)
jessica.a.su@gmail.com
Debbie Lawlor, Ph.D.
University of Bristol
Representing the Avon Longitudinal Study of Parents and Children (ALSPAC) and Born in Bradford (BiB)
d.a.lawlor@bristol.ac.uk
Ewy Mathé, Ph.D.
National Center for Advancing Translational Sciences
Representing the Longitudinal EMR and Omics COVID-19 Cohort (LEOCC)
ewy.mathe@nih.gov
Kevin Mendez, M.S.
Harvard Medical School and Brigham and Women’s Hospital
Representing the Genetic Epidemiology of Asthma in Costa Rica Cohort (GACRS)
rekme@channing.harvard.edu
Cristina Menni, Ph.D.
King's College London
Representing the Twins UK
cristina.menni@kcl.ac.uk
Rachel Murphy, Ph.D.
University of British Columbia
Representing the Health, Aging, and Body Composition Study (Health ABC)
rachel.murphy@ubc.ca
Megan Niedzwiecki, Ph.D.
Ichan School of Medicine at Mount Sinai
Representing the Programming Research in Obesity, Growth, Environment and Social Stressors (PROGRESS)
megan.niedzwiecki@mssm.edu
Matej Orešič, Ph.D.
University of Helsinki Finland
Representing the Diabetes Prediction and Prevention (DIPP) Birth Cohort
matej.oresic@gmail.com
Eric Orwoll, M.D.
Oregon Health and Science University
Representing the Osteoporotic Fractures in Men (MrOS)
orwoll@ohsu.edu
Jennifer Ose, Ph.D., M.Sc.
Huntsman Cancer Institute, University of Utah
Representing the ColoCare (COLO)
jennifer.ose@hs-hannover.de
Alexandre Pereira, Ph.D.
Harvard Medical School
Representing the Baependi Heart Study (BHS)
alexandre_pereira@hms.harvard.edu
Wei Perng, Ph.D.
Colorado School of Public Health
Representing Project Viva
wei.perng@gmail.com
Jackie Price, Ph.D.
The University of Edinburgh
Representing the Edinburgh Type 2 Diabetes Study (ET2DS)
jackie.price@ed.ac.uk
Rui Providencia, M.D., Ph.D.
University College London
Representing the British Women’s Heart and Health Study (BWHHS)
rui.providencia@ucl.ac.uk
Qibin Qi, Ph.D.
Albert Einstein College of Medicine
Representing the Women’s Interagency HIV Study (WIHS)
qibin.qi@einstein.yu.edu
Kathryn Rexrode, M.D., M.P.H.
Harvard Medical School and Brigham and Women's Hospital
Representing the Women's Health Initiative (WHI)
krexrode@partners.org
Denise Scholtens, Ph.D.
Northwestern University
Representing the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study
dscholtens@northwestern.edu
Wei Jie Seow, Ph.D.
National University of Singapore
Representing the Singapore Prospective Study Program (SP2)
ephswj@nus.edu.sg
Howie Sesso, Sc.D., M.P.H.
Brigham and Women's Hospital
Representing the Physicians' Health Study (PHS)
hsesso@hsph.harvard.edu
Svati Shah, M.D., M.H.S.
Duke Molecular Physiology Institute
Representing the Catheterization Genetics (CATHGEN) and Genetics of Early Onset Cardiovascular Disease (GENECARD)
svati.shah@duke.edu
Xiao-Ou Shu, M.D., Ph.D.
Vanderbilt University
Representing the Shanghai Men's Health Study (SMHS)
xiao-ou.shu@vanderbilt.edu
Gordon Smith, M.D., Ph.D.
University of Cambridge School of Clinical Medicine
Representing the Pregnancy Outcomes Prediction Study (POPS)
gcss2@cam.ac.uk
Victoria Stevens, Ph.D.
vstevens311@gmail.com
Isobel Stewart, Ph.D.
University of Cambridge School of Clinical Medicine
Representing the European Prospective Investigation into Cancer and Nutrition (EPIC), Norfolk
isobel.stewart@mrc-epid.cam.ac.uk
Therese Tillin, Ph.D.
University College London
Representing Southall and Brent Revisited (SABRE)
t.tillin@ucl.ac.uk
Kostas Tsilidis, Ph.D.
Imperial College London
Representing the Epirus Health Study
k.tsilidis@imperial.ac.uk
Katherine L. Tucker, Ph.D.
University of Massachusetts Lowell
Representing the Boston Puerto Rican Health Study (BPRHS)
katherine_tucker@uml.edu
Ioanna Tzoulaki, Ph.D.
Imperial College London
Representing the Airwave Health Monitoring Study (AIRWAVE)
i.tzoulaki@imperial.ac.uk
Jose M. Valdivielso, Ph.D.
IRBLleida Institute of Biomedical Research
Representing the Observatorio Nacional de Atherosclerosis en Nefrologia (NEFRONA)
valdivielso@medicina.udl.es
Ying Wang, Ph.D.
American Cancer Society
Representing Cancer Prevention Study – II (CPS-II)
ying.wang@cancer.org
Rui Wang-Sattler, Ph.D.
Helmholtz Zentrum München
Representing the Kooperative Health Research in the Region of Augsburgn (KORA)
rui.wang-sattler@helmholtz-muenchen.de
Craig Wheelock, Ph.D.
Karolinska Institute
Representing the PartnErs Gunma ASthma Study (PEGASUS)
craig.wheelock@ki.se
Sara White, Ph.D.
King's College London
Representing the UK Pregnancies Better Eating and Activity Trial (UPBEAT)
sara.white@kcl.ac.uk
James Wilson, D.Phil
Usher Institute, University of Edinburgh
Representing the Orkney Complex Disease Study (ORCADES)
jim.wilson@ed.ac.uk
Andrew Wong, Ph.D.
Medical Research Council (UK)
Representing Medical Research Council National Survey of Health and Development (MRC NSHD)
andrew.wong@ucl.ac.uk
Bing Yu, Ph.D.
University of Texas Health Science Center at Houston (UTHealth)
Representing the Atherosclerosis Risk in Communities Study (ARIC)
bing.yu@uth.tmc.edu
Hua Zhao, Ph.D.
Fred Hutchinson Cancer Research Center
Representing the Mano-A-Mano, the Mexican American Cohort (MAC)
hzhao2@mdanderson.org
Cohort Studies Participating in COMETS
Cohort | Funded By |
---|---|
Age Related Eye Disease Studies (AREDS/AREDS2) | National Eye Institute |
The Age Related Macular Degenerated Cohort (AMD) | Commonwealth Grant, Massachusetts Eye and Ear Discretionary Fund, and the Portuguese FCI |
Airwave Health Monitoring Study (AIRWAVE) | UK Government Home Office, UK National Institute for Health Research, Imperial College Biomedical Research Centre, UK Medical Research Council, UK MEDical BIOinformatics Partnership |
Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (ATBC) | Intramural Research Program of the National Cancer Institute at the National Institutes of Health and by U.S. Public Health Service |
Atherosclerosis Risk in Communities Study (ARIC) | National Heart, Lung and Blood Institute and the National Human Genome Research Institute |
Avon Longitudinal Study of Parents and Children (ALSPAC) | The UK Medical Research Council, the University of Bristol, the British Heart Foundation, and the Wellcome Trust and Joint UK Research Councils via the Lifelong Health and Wellbeing Programme |
Baependi Heart Study (BHS) |
Hospital Samaritano, FAPESP |
Born in Bradford (BiB) | The Wellcome Trust, the UK Medical Research Council (MRC) and UK Economic and Social Science Research Council (ESRC), and the National Institute for Health Research (NIHR) |
Boston Puerto Rican Health Study (BPRHS) | National Institutes of Health |
Breast Cancer Family Registry (BCFR) | National Cancer Institute |
British Women’s Heart and Health Study (BWHHS) | British Heart Foundation and NHS Digital |
Caerphilly Prospective Study (CaPS) | UK Medical Research Council and the Alzheimer’s Society UK |
Cancer Prevention Study – II (CPS-II) | American Cancer Society |
Catheterization Genetics (CATHGEN) | National Heart, Lung and Blood Institute |
Childhood Asthma Management Program (CAMP) | National Heart, Lung and Blood Institute |
ColoCare (COLO) | National Cancer Institute |
COloRectal Cancer Study of Austria (CORSA) | Austrian Science Fund, Austria Research Promotion Agency |
COPD Gene Epidemiology | National Heart, Lung and Blood Institute |
COpenhagen Prospective Studies on Asthma in Childhood (COPSAC) 2010 | The Lundbeck Foundation; Danish State Budget; Danish Council for Strategic Research; Danish Council for Independent Research and The Capital Region Research Foundation |
Diabetes Prediction and Prevention (DIPP) Birth Cohort | Juvenile Diabetes Research Foundation and Academy of Finland |
Diabetes Prevention Program Outcomes Study (DPPOS) | National Institute of Diabetes and Digestive and Kidney Diseases, National Cancer Institute, National Eye Institute, National Institute of Aging, and National Heart, Lung, and Blood Institute |
Edinburgh Type 2 Diabetes Study (ET2DS) | Medical Research Council, Chief Scientist Office of Scottish, Pfizer plc (Unrestricted Investigator Led Grant), and Diabetes UK Clinical Research Fellowship |
Emory African American Maternal-Child Cohort (Emory AA Maternal-Child Cohort) | NIEHS Environmental Influences on Child Health Outcomes (ECHO) Program |
Epirus Health Study (EHS) | Prefecture of Epirus, Greece |
The Estonian Biobank (EBB) | |
European Prospective Investigation into Cancer and Nutrition (EPIC) | World Cancer Research Fund, Cancer Research UK, French National Cancer Institute, and European Commission |
Fenland Study | UK Medical Research Council |
Finrisk 1997 | National Institute for Health and Welfare, Finland |
Finrisk 2002 | National Institute for Health and Welfare, Finland |
Finrisk 2007 | National Institute for Health and Welfare, Finland |
Finrisk 2012 | National Institute for Health and Welfare, Finland |
Framingham Heart Study | National Heart, Lung and Blood Institute |
Genetic Epidemiology of Asthma in Costa Rica Cohort (GACRS) | National Heart, Lung and Blood Institute |
Genomewide Scan for Early-Onset Coronary Artery Disease (GENECARD) | |
Genodiab-Mar (GDM) | Instituto de Salud Carlos III and Spanish Renal Research Network (RedinRen) |
The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study | National Institutes of Diabetes and Digestive and Kidney Diseases |
Health 2000 | National Institute for Health and Welfare, Finland |
Health, Aging, and Body Composition Study (Health ABC) | National Institute on Aging |
Health Professional Follow-up Study (HPFS) | National Cancer Institute |
Hong Kong Osteoporosis Study (HKOS) | |
Human Early Life Exposome Study Sub-cohort (HELIX) | European Union Seventh Framework Programme |
Kooperative Health Research in Augsburg (KORA) | Federal Ministry of Education and Research, the State of Bavaria, the Federal Ministry of Health, the German Research Foundation, and the European Union |
Longitudinal EMR and Omics COVID-19 Cohort (LEOCC) | |
Mano a Mano, the Mexican American Cohort (MAC) | National Cancer Institute |
Mass General Brigham (MGB)-Biobank Asthma | National Heart, Lung, and Blood Institute |
Medical Research Council National Survey of Health and Development (MRC NSHD) | UK Medical Research Council and British Heart Foundation |
Multiethnic Cohort (MEC) | National Cancer Institute |
Multi-Ethnic Study of Atherosclerosis (MESA) | National Heart, Lung and Blood Institute |
Normative Aging Study (NAS) | Department of Defense Congressionally Directed Medical Research Programs, U.S. Army Medical Research and Development Command |
Northern Sweden Health and Disease Study (NSHDS) | World Cancer Research Fund |
Nurses' Health Studies (NHS) | National Cancer Institute |
Nurses’ Health Studies II (NHS-II) | National Cancer Institute |
Observatorio Nacional de Atherosclerosis en Nefrologia (NEFRONA) | ABBOTT laboratories and the Instituto de Salud Carlos III |
Orkney Complex Disease Study (ORCADES) | Royal Society, EU FP6, Arthritis UK, and the Medical Research Council, UK |
The Osteoporotic Fractures in Men (MrOS) Study | National Heart, Lung and Blood Institute |
PartnErs Gunma Asthma Study (PEGASUS) | National Institutes of Health and Gunma University |
Physician's Health Study (PHS) | National Cancer Institute |
Pregnancy Outcomes Prediction Study (POPS) | The Cambridge Biomedical Research Centre (BRC) |
Programming Research in Obesity, Growth, Environment, and Social Stressors (PROGRESS) | National Institute of Environmental Health Sciences |
Project Viva | National Institutes of Health |
Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) | National Cancer Institute |
The Rotterdam Study (RS) | Erasmus MC, the Netherlands |
Shanghai Men's Health Study (SMHS) | National Cancer Institute |
Shanghai Physical Activity Study (SPA) | National Cancer Institute |
Shanghai Women's Health Study (SWHS) | National Cancer Institute |
Swedish Infrastructure for Medical Population-based Life-course and Environmental Research (SIMPLER) | Swedish Research Council |
Singapore Prospective Study Program (SP2) | National University of Singapore Start-Up Grant; National Medical Research Council, Clinician Scientist Award, Ministry of Health Alignment Fund, Janssen Pharmaceuticals Inc; National Kidney Foundation |
Southall and Brent Revisited (SABRE) | Wellcome Trust and British Heart Foundation |
Southern Community Cohort Study (SCCS) | National Institutes of Health |
SubPopulations and InteRmediate Outcome Measures in COPD Study (SPIROMICS) | National Heart, Lung, and Blood Institute, COPD Foundation |
Tsuruoka Metabolomic Cohort Study (TMCS) | Yamagata Prefectural Government, the city of Tsuruoka and the Japan Society for the Promotion of Science |
TwinsUK | Wellcome Trust; European Community's Seventh Framework Programme, National Institute for Health Research - funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London |
UK Pregnancies Better Eating and Activity Trial (UPBEAT) | UK National Institute for Health Research |
Vitamin D Antenatal Asthma Reduction Trial (VDAART) | National Heart, Lung and Blood Institute |
Well for Life-China (WELL-CHINA) | Gift funding to Stanford |
Whitehall II (WH-II) | The Medical Research Council, The British Heart Foundation, and National Institute on Aging |
Women's Health Initiative (WHI) | National Heart, Lung and Blood Institute |
Women’s Interagency HIV Study (WIHS) | National Cancer Institute, National Institute of Allergy and Infectious Diseases, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute on Drug Abuse, National Institute of Mental Health, National Institute of Dental and Craniofacial Research, National Institute on Alcohol Abuse and Alcoholism, National Institute on Deafness and other Communication Disorders, and NIH Office of Research on Women's Health |
Applying to Join COMETS
Researchers Representing Cohort Studies
Cohorts must meet the following criteria to participate in COMETS:
- Prospective cohort, 100+ participants with blood metabolomics data
- Identified metabolite data
- Follow-up for disease, including cancer and non-cancer outcomes
- Mass-spectrometry and NMR platforms are eligible
Researchers representing cohorts who want to participate in COMETS should apply through the Steering Committee membership form. The completed form should be emailed to Luciana Crotti Espinoza and Kelly Crotty. Membership will be considered by the COMETS Executive Committee. Every participating cohort is allowed a primary representative to serve on the COMETS Steering Committee. Steering Committee members meet monthly to review new project proposals, share research progress, and update on interest group activities.
Non-Steering Committee Membership
Researchers working in the field of metabolomic epidemiology who do not represent a cohort study can join as consortium members. Consortium members can propose new projects, join interest groups, and attend COMETS meetings, but do not have voting rights. Membership requires a nomination by a Steering Committee member and will be considered by the COMETS Executive Committee. Researchers, including trainees, interested in becoming a consortium member should fill out the consortium membership application form and email it along with their CV to Luciana Crotti Espinoza and Kelly Crotty (CCing the nominating Steering Committee member).